麻豆传媒

A look back at newsworthy stories of 2024

Researchers observed dose-response relationship for increasing BMI and long COVID risk

No benefit for brain fog or fatigue, but higher doses may have promise

Secondary analysis of trial data consistent with observational studies

Summer waves, long COVID data, and hope on the horizon

While 14 symptoms were common in both groups, differences also emerged

Lab tests can rule out other conditions, but are not biomarkers for long COVID

Some early pandemic patients dropped IQ points and did not return to their jobs

Experts unpack what recent outbreaks mean for public health

However, metabolic and gastrointestinal sequelae increased among the unvaccinated

Overly broad criteria won't help patients in the long run

Committee urges adoption, says it will aid in consistent diagnosis, documentation, and treatment

Trial had been stopped early for lack of efficacy

An unexpected idea gains traction and may provide clues about long COVID